MICROCAP LEADERSHIP SUMMIT

Similar documents
Genomic Health. Kim Popovits, Chairman, CEO and President

Uroplasty, Inc. Investor Update Canaccord Genuity Conference December 6, 2011

Emisphere Technologies, Inc. Announces 2008 Second Quarter Financial Results

Summary of Results for the First Half of FY2015/3

Myriad Genetics Fiscal First-Quarter 2017 Earnings Call 11/01/2016

Clovis Oncology Announces Q Operating Results and Corporate Update. November 3, :05 PM ET

J.P. Morgan. 27 th Annual Healthcare Conference. San Francisco January 14 th, 2009

NewLink Genetics Corporation Provides Operational Update and Reports Second Quarter 2015 Financial Results

1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes

HIGH CLINICAL ACCEPTANCE OF METVIX PDT

SPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS

Bank of America 38 th Annual Investment Conference. San Francisco, CA September 17 th, 2008

Telekom Austria Group Results for the 1st Quarter May 27, 2003

METVIX PDT ON THE MARKET IN GERMANY AND UK

HALOZYME REPORTS SECOND QUARTER 2018 RESULTS

January 30, 2018 Dow Wilson President and Chief Executive Officer

Annual Shareholders Meeting

Forward-Looking Statements

Infinity Highlights Promising Preclinical Hedgehog Data and Announces First Quarter Financial Results

ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015

FY2007 Consolidated Financial Overview

SPY Imaging for Surgeons

Oncolytics Biotech Inc. Announces Third Quarter 2010 Results

Increase in revenues in line with full-year targets (+1.2%) Very strong growth of Oralair exc. USA (+26%) H revenues and results - 24 July 2014

Investor Presentation June 2012 NASDAQ: CEMI

Growth in core businesses offsets weaker non-interest income. DBS Group Holdings 1Q 2005 Financial Results Presentation to Media and Analysts

Medifocus, Inc. OTCQX: MDFZF TSXV: MFS

Economic Implications of Advancements in Radiation Technology. Dramatic Growth of RT Capacity in the US

Immunity for Life TM. Third Quarter CEO Lars Viksmoen CFO Finn Samuelsen. 31 October 2007

Presentation First quarter 2006

Monogram Announces 2008 Second Quarter Financial Results

DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM

First Quarter Results to March 31, Shire plc April 25, 2008

Interim report Second quarter 2017 and subsequent events (Unaudited)

Special Meeting in Lieu of Annual Meeting of Shareholders

M e d i a s e t G r o u p

Sunesis Pharmaceuticals Reports Second Quarter 2011 Financial Results

Oncology Therapeutics without Compromise APRIL 2011

Zealand Pharma A/S Interim report for Q (un-audited)

INVESTOR MEETING ASTRO 2013

Argos Therapeutics Reports Fourth Quarter and Year-End 2013 Financial Results

For personal use only

REATA PHARMACEUTICALS, INC. ANNOUNCES SECOND QUARTER 2018 FINANCIAL RESULTS AND AN UPDATE ON DEVELOPMENT PROGRAMS

BancAnalysts Association of Boston Conference Presentation. November 3, 2017

For personal use only

PhotoCure ASA. Presentation. Results 1 Quarter 2004

Myriad Genetics Fiscal First-Quarter 2019 Earnings Call 11/06/2018

ObsEva Reports First Quarter 2018 Financial Results and Provides Business Update

THIRD QUARTER REPORT 2011 (UNAUDITED)

Myriad Genetics Fiscal Third-Quarter 2017 Earnings Call 05/02/2017

WntResearch. 100% one-week return? 16 October 2017 PRICE EXPECTATIONS INVESTMENT CASE PRICE TRIGGERS PRICE 12 MONTHS COMPANY PROFILE

Company overview. Highlights for the 1 st quarter 2018 (January-March)

Aerpio Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

Korean Airlines Q Results

Q Investor Kit JANUARY-JUNE 2013

ObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update

Fiscal 2019 Annual Meeting of Shareholders December 18, Presentation by Lori Woods, Chief Executive Officer

Mercy Health Corporation (WI)

Q Investor Kit January December 2014

JP MORGAN HEALTHCARE CONFERENCE DOW R. WILSON President and Chief Executive Officer 1 FOR INVESTOR USE ONLY

RADIOTHERAPY: TECHNOLOGIES AND GLOBAL MARKETS

Company Overview February 26, 2019

ThromboGenics Business Update H1 2018

Evofem Biosciences Reports Second Quarter 2018 Financial Results and Provides Corporate Update

Hyundai Motor Company 1 st Quarter 2011 Business Results. April 28, 2011

ObsEva Reports Third Quarter 2018 Financial Results and Provides Business Update

ELICA 2012 Q3 RESULTS. November 14,

34 th Annual J.P. Morgan Healthcare Conference

About Cancer Research UK

UCB, with a strong year 2017, is reinforcing a solid foundation for investing in future growth

Press release Regulated information

Intercept Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Business Update

Q Investor Kit JANUARY-MARCH 2014

Sumitomo Dainippon Pharma to Acquire Tolero Pharmaceuticals, Inc. (US Biotechnology Company)

DS-8201 Strategic Collaboration

BALCHEM CORPORATION. Q Investor Relations Presentation

Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy

Q Investor Kit JANUARY-MARCH 2013

ThromboGenics Business Update H1 2017

Q Investor Kit JANUARY-JUNE 2014

FROM ICARO1 TO ICARO2: THE MEDICAL PHYSICS PERSPECTIVE. Geoffrey S. Ibbott, Ph.D. June 20, 2017

HILLENBRAND INDUSTRIES INC

Sunesis Pharmaceuticals Reports Third Quarter 2014 Financial Results and Recent Highlights

Q3 18 Earnings Supplemental Slides

Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy

Investor Presentation April NYSE American: ISR

37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE

Building a Premier Oncology Biotech

DARA Reports Year-End 2012 Financial Results

DELICA D:5 ACTIVE GEAR 0

Shareholder Presentation 2017 NYSE MKT: ISR

4Q and Full Year 2017 Financial Results Call February 7, 2018

COMPANY OVERVIEW. April 26, 2018

RULES OF CONDUCT OF INSIDERS RESPECTING

Universal Biosensors, Inc.

Safe Harbor Statement

Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy

artnet AG Quarterly Interim Statement for the First Quarter of 2016 artnet AG Quarterly Interim Statement for the First Quarter of 2016

USA National Mental Healthcare Nonprofit Exempt Organization Financial Analysis as of December 14, 2015 January 24, 2016 ANSA-H2

First Albany Orthopedics Conference Marina Village, San Diego February 13, 2007 Orthofix International

Transcription:

MICROCAP LEADERSHIP SUMMIT WESTIN CHICAGO NORTHWEST HOTEL ITASCA, IL SEPTEMBER 23, 2016

SAFE HARBOR STATEMENT This presentation may be deemed to contain certain forward-looking statements with respect to the financial condition, results of operations and future plans of American Shared Hospital Services, which involve risks and uncertainties including, but not limited to, the risks of the Gamma Knife, radiation therapy and proton beam therapy businesses, the risks of the timing, financing, operations, and profitability of the Company s businesses and related market-based risks. Further information on potential factors that could affect the financial condition, results of operations and future plans of American Shared Hospital Services is included in the filings of the Company with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K for the year ended December 31, 2015, Quarterly Report on Form 10-Q for the quarters ended on March 31, 2016 and June 30, 2016 and the definitive Proxy Statement for the Annual Meeting of Shareholders held on June 21, 2016. American Shared Hospital Services 2

BUSINESS OPERATIONS CURRENT OPERATIONS Radiosurgery Linear Accelerator Based Radiation Therapy Proton Beam Radiation Therapy 17 Centers 1 Center 1 Center American Shared Hospital Services 3

GAMMA KNIFE + Gold Standard for Cranial Radiosurgery + Typical Project Cost $3 - $4 million American Shared Hospital Services 4

PROTON THERAPY + Historically, centers were 3-5 treatment room centers costing $150 - $200 million or more + New single room systems by Mevion Medical Systems and others have reduced the average cost per treatment rooms to $25 - $35 million American Shared Hospital Services

ASHS - BUSINESS MODEL + Structured as a (alternative) leasing company + Innovative financing features not available from traditional finance companies American Shared Hospital Services 6

ASHS - BUSINESS MODEL + Long Term Agreements Typically 10 years + Revenue Sharing or Fee Per Use NO MINIMUM VOLUME GUARANTEES American Shared Hospital Services 7

ASHS - BUSINESS MODEL ASHS RESPONSIBILITIES + Acquire equipment + Equipment related operating expenses + Jointly fund marketing American Shared Hospital Services 8

ASHS - BUSINESS MODEL HOSPITAL S RESPONSIBILITIES + Site costs + Operating costs, excluding those covered by American Shared + Jointly fund marketing American Shared Hospital Services 9

GAMMA KNIFE TREATMENT INDICATIONS + Malignant Brain Tumors Metastatic Brain Tumors (180,000 250,000 Diagnosed Annually) + Benign Brain Tumors + Trigeminal Neuralgia (Facial Pain) + Vascular Malformations American Shared Hospital Services 10

ASTRO RECOMMENDATION Don t routinely add adjuvant whole brain radiation therapy to stereotactic radiosurgery for limited brain metastases 2014 Choosing Wisely List- American Society for Radiation Oncology (ASTRO). (n.d.). Retrieved from https://www.astro.org/patient-care/patient-education/2014- Choosing-Wisely-List/. American Shared Hospital Services 11

ASHS - GAMMA KNIFE PARTNERS 1. Methodist Healthcare System San Antonio, TX 2. Yale-New Haven Hospital New Haven, CT 3. Kettering Medical Center Kettering, OH 4. Tufts Medical Center Boston, MA 5. University of Arkansas for Medical Sciences Little Rock, AR American Shared Hospital Services 12

ASHS - GAMMA KNIFE PARTNERS 6. JFK Medical Center Edison, NJ 7. Sunrise Hospital and Medical Center Las Vegas, NV 8. Central Mississippi Medical Center Jackson, MS 9. OSF Healthcare Peoria, IL 10. Albuquerque Regional Medical Center Albuquerque, NM 11. Northern Westchester Hospital Mt. Kisco, NY American Shared Hospital Services 13

ASHS - GAMMA KNIFE PARTNERS 12. Mercy Health Center Oklahoma City, OK 13. USC University Hospital Los Angeles, CA 14. Fort Sanders Regional Medical Center Knoxville, TN 15. St. Vincent s Medical Center Jacksonville, FL 16. Sacred Heart Hospital Pensacola, FL 17. PeaceHealth Sacred Heart Medical Center at RiverBend Springfield, OR American Shared Hospital Services 14

ASHS RADIATION THERAPY PARTNER - LINAC 1. Tufts Medical Center Boston, MA American Shared Hospital Services

ASHS - FINANCIAL HIGHLIGHTS ($000 s) 6 Months 2016 6 Months 2015 2015 Medical Services Revenue 8,756 8,511 16,548 EPS.03 (.34) (.28) Adjusted EPS 1.04 2.05 3.11 3 Adjusted EBITDA 1 4,457 2 4,365 3 8,656 3 Net Book Value 25,690 24,602 25,180 Common Shares Outstanding 5,368 5,364 5,364 (1) Non-GAAP. See slides elsewhere in this presentation for reconciliations of Adjusted EPS and Adjusted EBITDA to GAAP EPS and GAAP Net Income, respectively. (2) Excludes early exiting investment of debt (3) Excludes investment write-down American Shared Hospital Services 16

ASHS - RECONCILIATION OF NON-GAAP RESULTS OF OPERATIONS TO THE NEAREST COMPARABLE GAAP MEASURES ($000 s) 6 Months 2016 6 Months 2015 2015 EPS.03 (.34) (.28) Per Share Adjustments: Early Extinguishment of Debt, Net of Estimated Tax Loss on Write Down Investment in Equity Securities.01 0 0 0.39.39 Adjusted EPS.04.05.11 American Shared Hospital Services 17

ASHS ADJUSTED EBITDA ($000 s) 6 Months 2016 6 Months 2015 2015 Net Income (loss) 144 (1,842) (1,522) Plus: Income Tax Expense 157 236 434 Interest Expense 718 665 1,239 Depreciation and Amortization Expense 3,211 3,098 6,139 Share-Based Payment 119 94 226 Loss on Write Down of Investment 0 2,114 2,140 Early Extinguishment of Debt 108 0 0 Adjusted EBITDA 4,457 4,365 8,656 American Shared Hospital Services 18

ASHS - BALANCE SHEET ASSETS ($000 s) June 30, 2016 TOTAL CURRENT ASSETS $6,527 Property & Equipment, Net $51,800 Investment In Preferred Stock & Other Assets $974 Total Assets $59,301 LIABILITIES & SHAREHOLDERS' EQUITY CURRENT LIABILITIES Payables & Other Liabilities $1,854 Current Debt & Leases $7,723 TOTAL CURRENT LIABILITIES $9,577 Long-term Debt & Leases $19,791 Deferred Revenue $663 Deferred Income Taxes $3,580 Total Shareholders' Equity $25,690 Total Liabilities & Shareholders' Equity $59,301 American Shared Hospital Services 19

ASHS - PROTON BEAM RADIATION THERAPY + NOT A NEW technology + Clinically Advantageous American Shared Hospital Services 20

PROTON THERAPY INDICATIONS TREATED + Prostate + Breast + Head and Neck + Lymphomas + Lung + Central Nervous System + Liver + Pediatric + GI American Shared Hospital Services 21

ASHS - PROTON BEAM PARTNERS 1. The Marjorie and Leonard Williams Center for Proton Therapy at UF Health Cancer Center - Orlando Health

WHAT MAKES PROTON THERAPY SPECIAL + Protons deposit dose at tumor, versus x-rays passing through the tumor + Minimize damage to surrounding tissue American Shared Hospital Services 23

ASHS - BRAGG PEAK PHENOMENA 15 MV PHOTONS vs SOBP PROTONS American Shared Hospital Services 24

ASHS - PHOTON VS. PROTON PEDIATRIC MEDULLOBLASTOMA Photon Beam Delivery % Dose Recommended 100 50 Proton Beam Delivery 10 American Shared Hospital Services 25

ASHS - UNITED STATES PBRT MARKET ANALYSIS PBRT CAPTURE RATE 15% 2 30% 3 Number of radiation therapy patients annually in the U.S. 1 995,000 995,000 Percent of radiation therapy patients eligible for PBRT Number of potential PBRT patients in the U.S. 15% 30% 149,250 298,500 Potential PBRT room market* 597 1,194 *Assumed 250 patients treated annually per PBRT room (1) The American Cancer Society indicates that 1,658,370 people in the United States will be diagnosed with cancer in 2014. Approximately 60% of these people will receive radiation treatment. (2) Number of Patients Potentially Eligible for Proton Therapy, Acta Oncologica 2005; 44; 836-849; Bengt Glimelius, Anders Ask, Et. Al. (3) Evaluation of Potential Proton Therapy Utilization in a Market Based Environment, Tomas Dvorak, M.D. and David E. Wazer, M.D. American Shared Hospital Services 26

ASHS - PBRT OPPORTUNITY + Currently only 24 PBRT centers in U.S. + 10 PBRT centers under development in U.S. Particle Therapy Co-Operative Group. Retrieved from http://www.ptcog.ch/ American Shared Hospital Services 27

ASHS - PROTON THERAPY STRATEGY + Develop single room proton beam radiation therapy centers with major hospitals American Shared Hospital Services 28

PROTON THERAPY MARKET ANALYSIS + Current Medicare Reimbursement: approximately $1,150 per fraction (daily session). A course of treatment runs 25-30 fractions + Established centers typically treat 20-35 patients per day, per treatment room American Shared Hospital Services 29

PROTON THERAPY MARKET ANALYSIS + Utilizes same business model as the Gamma Knife. Expect margins to be similar + For ASHS, each treatment room offers potential for substantial incremental revenue and EBITDA American Shared Hospital Services 30

ASHS - MANAGEMENT TEAM MANAGEMENT TEAM Ernest A. Bates, M.D. Chairman and CEO Craig K. Tagawa COO and CFO Ernest R. Bates V.P. of Sales and Business Development Years of Healthcare Experience 30+ 30+ 10+ American Shared Hospital Services 31

ASHS - SUMMATION + Supplier of Gamma Knife services since 1991 + Long-standing alliances with premier cancer centers American Shared Hospital Services 32

ASHS - SUMMATION POSITIONED FOR GROWTH IN EMERGING PROTON THERAPY MARKET + Development and financing of Orlando project establishes ASHS proton bona fides + First proton therapy center now treating patients + Proton therapy provided modest revenue contribution in June quarter, more substantial in second half and beyond + Negotiating development of additional proton centers American Shared Hospital Services 33

2 Embarcadero Center, Suite 410 San Francisco, CA 94111 (415) 788-5300 www.ashs.com NYSE MKT:AMS